Concepedia

Katherine Ruzhansky

KR

Statistics

Publications

11

Citations

1.4K

H-Index

11

Active since

2013

Affiliations

University of North Carolina at Chapel Hill(Current)

Duke University

Medical University of South Carolina

University at Buffalo, State University of New York

University of South Florida

Katherine Ruzhansky is an author at University of North Carolina at Chapel Hill specializing in medicine, clinical trials, and outcomes research.

ORCID

Top concepts

Publications per year

2013–2025

11

Publications

11

Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial

James F. Howard, Vera Bril, Tuan Vu et al. · The Lancet Neurology · 2021 · 587 citations · Full text

,

Rituximab as treatment for anti-MuSK myasthenia gravis

Michael K. Hehir, Lisa D. Hobson‐Webb, Michael Benatar et al. · Neurology · 2017 · 243 citations

Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study

James F. Howard, Saskia Bresch, Angela Genge et al. · The Lancet Neurology · 2023 · 213 citations

, , +1

Causes of neuropathy in patients referred as “idiopathic neuropathy”

Khosro Farhad, Rebecca Traub, Katherine Ruzhansky et al. · Muscle & Nerve · 2015 · 96 citations

Thymectomy may not be associated with clinical improvement in MuSK myasthenia gravis

Katherine Clifford, Lisa D. Hobson‐Webb, Michael Benatar et al. · Muscle & Nerve · 2018 · 82 citations

1–5 of 11